I don't believe Gerald was referring to the RS in his reply, but only to Dr. Arad intent to finalize 3CL Sciences with Todos.
Unless significant news is released by end of March and share price is much higher, I am confident RS is off the table for now per Gerald's previous comments which have been consistent regarding postponing uplist until share price supports it. Gerald was very clear on the Investor Update Call a few months back that he has no desire to repeat what happened at Amarantus with the RS and failed uplist. I believe he is sincere on that, and it's not a concern for me.
I was waiting for transferred funds to clear today to buy more shares, but didn't get cleared in time. Will be buying tomorrow. IMO, the slow trend over last 3 weeks is due to lack of news, and spooked investors who wanted quicker returns in penny land. I've been taking advantage as much as possible. Still expecting great performance from this investment, even if recent decline has folks nervous.
News comes when it comes. In the meantime, Twitter gives us a little insight. Still very excited to be a shareholder here.
I made a post back in January that still holds true for me today. Stock performance has sucked, but happy with advances being made and understand this is hard work that takes time. Lots of great people working to make this happen. Gerald isn't operating in a vacuum here. Bright future for this company, IMO, and I'm continuing to load up. GLTA
News 
Market Data 
Discover 
AI
